Abstract:Chronic pancreatitis is a progressive fibrosis of the pancreas that leads to loss of endocrine and exocrine function. The most common symptom in this disease is intractable pain. The etiology of pain in chronic pancreatitis is not clearly understood. However, many of these patients have dilated ducts consisting of saccular dilations and intervening constructions referred to as the "chain of lakes" phenomenon. These patients can be diagnosed with either endoscopic retrograde cholangiopancreatography (ERCP) or c… Show more
“…(15) First described by Partington and Rochelle, the modified Puestow procedure is, in brief, a lateral pancreaticojejunostomy that involves side-to-side anastomosis of a longitudinal opening in the jejunum to a longitudinally opened PD. (27) The original Puestow procedure included splenectomy, distal pancreatectomy and longitudinal opening of the main PD with insertion of the pancreas into a Roux-en-Y limb of the jejunostomy, which then acts as a sleeve around the pancreas. (27) The Partington and Rochelle modification obviated the need for removal of the spleen and distal pancreas, and achieved extended drainage of the PD, which was not possible with the original Puestow procedure, where the proximal PD was left undrained because the jejunum could not be brought past the superior mesenteric vessels.…”
Section: Diagnosis and Investig Ationsmentioning
confidence: 99%
“…(27) The original Puestow procedure included splenectomy, distal pancreatectomy and longitudinal opening of the main PD with insertion of the pancreas into a Roux-en-Y limb of the jejunostomy, which then acts as a sleeve around the pancreas. (27) The Partington and Rochelle modification obviated the need for removal of the spleen and distal pancreas, and achieved extended drainage of the PD, which was not possible with the original Puestow procedure, where the proximal PD was left undrained because the jejunum could not be brought past the superior mesenteric vessels. (27) One of the key proposed advantages of Puestow and other drainage procedures over resection procedures is the preservation of pancreatic tissue, and hence, exocrine and endocrine functions of the pancreas.…”
Pancreaticopleural fistula is a rare diagnosis requiring a high index of clinical suspicion due to the predominant manifestation of thoracic symptoms. The current literature suggests that confirmation of elevated pleural fluid amylase is the most important diagnostic test. Magnetic resonance cholangiopancreatography is the recommended imaging modality to visualise the fistula, as it is superior to both computed tomography and endoscopic retrograde cholangiopancreatography (ERCP) in delineating the tract within the pancreatic region. It is also less invasive than ERCP. While a trial of medical regimen has traditionally been the first-line treatment, failure would result in higher rates of complications. Hence, it is suggested that management strategies be planned based on pancreatic ductal imaging, with patients having poor chances of spontaneous closure undergoing either endoscopic or surgical intervention. We also briefly describe a case of pancreaticopleural fistula in a patient who was treated using a modified Puestow procedure after failed endoscopic treatment.
“…(15) First described by Partington and Rochelle, the modified Puestow procedure is, in brief, a lateral pancreaticojejunostomy that involves side-to-side anastomosis of a longitudinal opening in the jejunum to a longitudinally opened PD. (27) The original Puestow procedure included splenectomy, distal pancreatectomy and longitudinal opening of the main PD with insertion of the pancreas into a Roux-en-Y limb of the jejunostomy, which then acts as a sleeve around the pancreas. (27) The Partington and Rochelle modification obviated the need for removal of the spleen and distal pancreas, and achieved extended drainage of the PD, which was not possible with the original Puestow procedure, where the proximal PD was left undrained because the jejunum could not be brought past the superior mesenteric vessels.…”
Section: Diagnosis and Investig Ationsmentioning
confidence: 99%
“…(27) The original Puestow procedure included splenectomy, distal pancreatectomy and longitudinal opening of the main PD with insertion of the pancreas into a Roux-en-Y limb of the jejunostomy, which then acts as a sleeve around the pancreas. (27) The Partington and Rochelle modification obviated the need for removal of the spleen and distal pancreas, and achieved extended drainage of the PD, which was not possible with the original Puestow procedure, where the proximal PD was left undrained because the jejunum could not be brought past the superior mesenteric vessels. (27) One of the key proposed advantages of Puestow and other drainage procedures over resection procedures is the preservation of pancreatic tissue, and hence, exocrine and endocrine functions of the pancreas.…”
Pancreaticopleural fistula is a rare diagnosis requiring a high index of clinical suspicion due to the predominant manifestation of thoracic symptoms. The current literature suggests that confirmation of elevated pleural fluid amylase is the most important diagnostic test. Magnetic resonance cholangiopancreatography is the recommended imaging modality to visualise the fistula, as it is superior to both computed tomography and endoscopic retrograde cholangiopancreatography (ERCP) in delineating the tract within the pancreatic region. It is also less invasive than ERCP. While a trial of medical regimen has traditionally been the first-line treatment, failure would result in higher rates of complications. Hence, it is suggested that management strategies be planned based on pancreatic ductal imaging, with patients having poor chances of spontaneous closure undergoing either endoscopic or surgical intervention. We also briefly describe a case of pancreaticopleural fistula in a patient who was treated using a modified Puestow procedure after failed endoscopic treatment.
“…The results of the Partington procedure in patients with chronic pancreatitis are summarized in Table 1 [3,[11][12][13][14][15][16][17][18][19][20]. This procedure relieves chronic abdominal pain in 66-91% of patients with a mean follow-up of 3.5-9.1 years.…”
Section: Outcome Of the Partington Proceduresmentioning
confidence: 99%
“…It is very important to note that the Partington procedure is used for inflammatory disease left of the gastroduodenal artery and specifically not used as the procedure of choice for inflammatory disease of the head of the pancreas. For the inflammatory pancreatic head mass, extended drainage procedures such as the original Frey procedure [6], minimum Frey procedure [26] and extended LPJ [3,25] should be employed.…”
Section: Partington Procedure-present Status and Future Considerationsmentioning
confidence: 99%
“…The two approaches were founded on differing pathophysiological theories of the etiology of the pain. Proponents of drainage procedures such as the lateral pancreaticojejunostomy (LPJ), which is also known as the modified Puestow procedure or Partington procedure, insist that decompressing the affected ductal system suffices, whereas proponents of resectional procedures such as pancreaticoduodenctomy insist that removing the portion of pancreas with affected neural tissue, especially the pancreatic head, is mandatory because the pancreatic head is a pacemaker in chronic pancreatitis [3].…”
Introduction For the surgical management of chronic pancreatitis with an inflammatory pancreatic head mass, extended drainage operations such as Beger and Frey procedures were established in the 1980s as an alternative to resectional procedures like pancreaticoduodenectomy and as opposed to simple drainage operations such as lateral pancreaticojejunostomy, that is, the Partington procedure. With the relatively rapid adoption of the two procedures, it seems that the Partington procedure has become a thing of the past. Materials and methods The Partington procedure was reevaluated with regard to the historical aspects and its present status by a literature review. Results The results show that this procedure relieves chronic abdominal pain in 66-91% of patients with a mean follow-up of 3.5-9.1 years. It is important to note that this procedure is generally used for inflammatory disease left of the gastroduodenal artery and is specifically not used as the procedure of choice for inflammatory disease of the pancreatic head. Conclusion For patients with a dilated main pancreatic duct but without an inflammatory pancreatic head mass, the Partington procedure is still the procedure of choice, since it is technically simple to perform with a minimum of morbidity and mortality, preserving pancreatic endocrine and exocrine function. Because it is a relatively simple technique, the laparoscopic approach will be justified as a treatment of appropriate patients in the near future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.